Live search
TopFind is fetching the latest matches for your search.
We reviewed 3640 live results for biologic drug substance manufacturing and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Manufacturing and Biotechnology.
Source: Amgen Singapore
Description
Large-scale production of biologic drug substances using next-generation manufacturing technologies. The facility focuses on producing medicines for critical therapeutic areas including oncology and bone health.
Best for
Large Scale biologic supply, Oncology drug manufacturing and Biopharmaceutical clinical trials
Rating
Source: Amgen Inc.
Description
Specialized production of biologic medicines that utilize living cells for therapy. These medical products address conditions in oncology, bone health, and inflammatory diseases, serving as a cornerstone of modern biopharmaceutical treatment.
Best for
Cancer treatment, Inflammatory disease therapy, Bone health management and Biotechnology research
Rating
Source: AstraZeneca
Description
A planned $1.5 billion advanced manufacturing facility in Singapore dedicated to producing antibody-drug conjugates. This project relocalises the production of complex medicines to ensure regional supply stability.
Best for
Biopharma sector development, Regional medicine supply, High Tech healthcare and Supply chain stability
Rating
| Compare | Biologic Drug Substance Manufacturing | Biologic Medicine Development and Manufacturing | Antibody-Drug Conjugate Manufacturing |
|---|---|---|---|
| Source | Amgen Singapore | Amgen Inc. | AstraZeneca |
| Description | Large-scale production of biologic drug substances using next-generation manufacturing technologies. The facility focuses on producing medicines for critical therapeutic areas including oncology and bone health. | Specialized production of biologic medicines that utilize living cells for therapy. These medical products address conditions in oncology, bone health, and inflammatory diseases, serving as a cornerstone of modern biopharmaceutical treatment. | A planned $1.5 billion advanced manufacturing facility in Singapore dedicated to producing antibody-drug conjugates. This project relocalises the production of complex medicines to ensure regional supply stability. |
| Best for | Large Scale biologic supply, Oncology drug manufacturing and Biopharmaceutical clinical trials | Cancer treatment, Inflammatory disease therapy, Bone health management and Biotechnology research | Biopharma sector development, Regional medicine supply, High Tech healthcare and Supply chain stability |
| Action | |||
| Rating |
If you want the most balanced option to start with, I recommend:
"Biologic Drug Substance Manufacturing from Amgen Singapore."
I picked this because Amgen is a world-renowned biotech brand with high-capacity manufacturing facilities in Singapore, ensuring high-quality biologic production.